MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with D

Dipyridamole

Dipyridamole 25mg tablets

No stability information

Stability notes for Dipyridamole 25mg tablets

There are no stability notes for this medicine.

Suppliers (5) of Dipyridamole 25mg tablets
Dipyridamole 25mg tablets (A A H Pharmaceuticals Ltd)
Dipyridamole 25mg tablets (Accord-UK Ltd)
Dipyridamole 25mg tablets (Medihealth (Northern) Ltd)
Dipyridamole 25mg tablets (Phoenix Healthcare Distribution Ltd)
Dipyridamole 25mg tablets (Sigma Pharmaceuticals Plc)

Dipyridamole 100mg tablets

No stability information

Stability notes for Dipyridamole 100mg tablets

There are no stability notes for this medicine.

Suppliers (7) of Dipyridamole 100mg tablets
Dipyridamole 100mg tablets (A A H Pharmaceuticals Ltd)
Dipyridamole 100mg tablets (Accord-UK Ltd)
Dipyridamole 100mg tablets (Alliance Healthcare (Distribution) Ltd)
Dipyridamole 100mg tablets (Genesis Pharmaceuticals Ltd)
Dipyridamole 100mg tablets (Medihealth (Northern) Ltd)
Dipyridamole 100mg tablets (Phoenix Healthcare Distribution Ltd)
Dipyridamole 100mg tablets (Sigma Pharmaceuticals Plc)

Dipyridamole 200mg modified-release capsules

No stability information

Stability notes for Dipyridamole 200mg modified-release capsules

There are no stability notes for this medicine.

Suppliers

Dipyridamole 200mg modified-release capsules (Dr Reddy's Laboratories (UK) Ltd)
Dipyridamole 200mg modified-release capsules (Medihealth (Northern) Ltd)
Dipyridamole 200mg modified-release capsules (Strides Pharma UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.